Haemonetics Acquires Vivasure Medical

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Second Sight Medical Products Completes Merger with Nano Precision Medical and Becomes Vivani Medical, Inc.

August 30, 2022

Biotechnology

Second Sight Medical Products completed its merger with Nano Precision Medical and changed its name to Vivani Medical, Inc., with the combined company trading on Nasdaq under the ticker VANI. The transaction brings approximately $55 million in cash to advance Nano Precision Medical's NanoPortal implant portfolio (including lead asset NPM-119) into clinical development and places Nano Precision CEO Dr. Adam Mendelsohn as CEO of the combined company.

Haemonetics Acquires Attune Medical

March 5, 2024

Medical Devices

Haemonetics Corporation has agreed to acquire privately-held Attune Medical, the maker of the FDA-cleared ensoETM esophageal cooling device, for $160 million upfront plus contingent consideration. The acquisition will expand Haemonetics' electrophysiology and temperature-management capabilities and is expected to close in Haemonetics' fiscal 2025 first quarter.

Haemonetics Corporation Acquires OpSens Inc.

December 12, 2023

Medical Devices

Haemonetics Corporation completed its acquisition of OpSens Inc. in an all-cash transaction for CAD $2.90 per share, representing a fully diluted equity value of approximately USD $255 million. The deal expands Haemonetics' hospital/interventional cardiology portfolio with OpSens' fiber-optic sensor technology (including the SavvyWire and OptoWire); OpSens will be delisted and Haemonetics expects OpSens to contribute $55–$65 million in revenue in fiscal 2025.

Surmodics Acquires Vetex Medical Limited

July 6, 2021

Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.

Viveon Health Acquisition Corp. to Merge with Suneva Medical

January 12, 2022

Medical Devices

Suneva Medical, a San Diego–based regenerative aesthetics medical technology company, has entered into a definitive merger agreement with special purpose acquisition company Viveon Health Acquisition Corp. The transaction will combine Suneva with the public SPAC vehicle (NYSE American: VHAQ) to provide growth capital and public-market access for Suneva, with the combined company expected to trade on the NYSE under the symbol "RNEW."